Supply guidance · Sources checked October 12, 2026

Estrogen patch shortage: check your brand and next steps

By Iacob Pastina · Independent editorial guide

Estradiol patch availability depends on the product and pharmacy. The FDA's September 3, 2026 statement says patches remain available despite access difficulties. ASHP's product-level bulletin is dated August 12, 2026. Both sources were checked October 12. The table below contains dated manufacturer reports, so confirm your exact prescription with your dispensing pharmacy.

If it cannot be filled, contact your prescriber before changing treatment. This page separates systemic alternatives from local vaginal treatments and helps you compare care fees if you need another clinician. The Estradiol Patch Alternative Tracker lists provider treatment options; it cannot confirm a shipment or a prescription for you.

What should I ask if my pharmacy cannot fill my patch?

Have your prescription or box ready so the pharmacy can check the exact product. You can ask:

Is my brand or manufacturer, strength and package size in stock, or can you order it?
Is an appropriate substitute available, and would my prescriber need to issue a new prescription?
When should I check again, and what should I ask my prescriber if I will run out first?

Keep your prescriber involved before stopping or changing treatment. Our estradiol brand guide separates brands, application schedules and label information; it is not a dose-conversion tool.

Based on the FDA's advice for patients.

Which estrogen patches are available?

Manufacturer supply varies by strength and package. Pharmacy stock is unverified; confirm your exact prescription with the dispensing pharmacy before booking or switching providers.

ASHP supply bulletin: August 12, 2026. Read October 12, 2026. See every strength by manufacturer, with FDA checks and history.

Patch	Manufacturer supply	Strength / package detail
ClimaraLyllana	Listed available	All listed strengths.
Dotti	Varies by strength	0.025, 0.05 and 0.075 mg/day available; 0.0375 and 0.1 mg/day backordered without a release estimate.
Sandoz	Supply restricted	0.0375 and 0.1 mg/day backordered; remaining strengths allocated.
Noven / Grove	Intermittent back orders	Weekly supply releases.
Zydus	On allocation	All presentations.
Viatris	Package-specific restriction	0.05 mg/day, 8-count, NDC 00378-4642-26: intermittent back orders. Other listed products available.

Compare prescribers and alternative forms →

How bad is the estrogen patch shortage right now?

A national shortage report cannot tell you which pharmacy has your prescription. The manufacturer table above identifies affected strengths and packages in the dated ASHP bulletin. Different strengths of the same brand may have different supply reports. Bring the exact product name and strength from your prescription when you contact the pharmacy.

Source: ASHP estradiol transdermal system bulletin, August 12, 2026.

Which estrogen patches are available right now?

In ASHP's bulletin dated August 12, 2026, Climara and Lyllana are listed available in all listed strengths. Dotti is available at 0.025, 0.05 and 0.075 mg/day, while its 0.0375 and 0.1 mg/day strengths are back-ordered. Viatris lists one 0.05 mg/day package on intermittent back order and its other listed products available. Sandoz, Zydus and Noven report restricted, allocated or intermittent supply.

These are manufacturer reports, not your pharmacy's shelf. If your strength is short, ask your pharmacist whether an available product in the same FDA equivalence group can be dispensed, and ask your prescriber before you change brand, strength or schedule. The generic makers table shows which patches share a group.

Source: ASHP estradiol transdermal system bulletin, dated August 12, 2026 and checked October 12, 2026.

Is anyone doing anything about the estrogen patch shortage?

The FDA reported on September 3, 2026 that supply had nearly doubled over the past year. It is working with six manufacturers on measures including production shifts, equipment and capacity. The agency also offers expedited review of supply-related submissions when appropriate.

If your prescription cannot be filled, the practical next step remains a pharmacist and prescriber conversation.

Is there an estrogen patch shortage in 2026?

ASHP lists affected estradiol patch products in its August 12 bulletin. A product can appear there while another brand or strength remains available. The FDA's September update acknowledges difficulty accessing usual patches. These sources describe different parts of the supply picture, and neither is a real-time inventory feed for pharmacies.

Sources: ASHP bulletin; FDA update above.

Where can I check national reports and local stock?

Read the FDA Drug Shortages page and ASHP's estradiol bulletin for national reporting. Check the publication date on each source. Your dispensing pharmacy must confirm local stock and whether it can order the exact product on your prescription.

Why can't I fill my estrogen patch?

The FDA links increased demand to greater interest in menopause treatment following its November 2025 labeling action. Transdermal patches require specialized manufacturing, so capacity changes can take time. The pharmacy can help distinguish a problem with your particular product from a broader supply issue.

Source: FDA supply update, September 3, 2026.

How long will the estrogen patch shortage last?

There is no reliable end date for every brand and strength. The FDA's September 3 update describes ongoing production work without giving a single resolution date. Ask your pharmacy when to check again and your prescriber what to do if your refill will run out first.

Source: FDA supply update.

What can I use instead of an estrogen patch?

The option depends on what your patch treats and your medical history. Bring these questions to your prescriber and pharmacist:

Another patch: can an appropriate brand or generic be substituted, or does the prescription need to change?
A systemic gel, spray or oral product: would it treat your symptoms, and what dose, precautions and cost would apply?
A vaginal ring: which product is intended? Femring's label includes hot flashes. Estring's indication is vulvar and vaginal atrophy, so it should not be presented as an interchangeable hot-flash treatment.
Handling your current patches: do not cut them, combine strengths or change the application schedule without specific instructions. ASHP describes the dose-release and stability concerns.

Compounded products do not have FDA approval. A clinician should discuss the evidence and whether an FDA-approved option meets your needs before selecting treatment.

Estradiol gel vs patch: what is the actual difference?

A patch stays attached between scheduled changes; gel requires daily application according to its label. Divigel's FDA-approved labeling includes menopausal hot flashes, as do several estradiol patches. This shared indication does not establish a direct dose conversion or prove the products are interchangeable.

Ask your prescriber about application instructions, skin contact precautions and your individual risks. Ask your pharmacy for the full prescription cost under your insurance or cash-pay arrangement before changing treatment. The brand and label comparison links each named product to its recorded indication and schedule.

Estrogen patch alternatives: who prescribes each form

The table below groups published provider options by form. Read each product's description carefully: some are systemic treatments, some address local vaginal symptoms, and some are compounded. A listed treatment is a conversation to have with a clinician, not a recommendation to switch or proof of current pharmacy stock. For patch schedules and published costs, see the estrogen patch guide.

Estradiol gel

3 providersFDA route for Divigel: topical

Estradiol spray

0 providersFDA route for Evamist: transdermal

None of the featured menopause providers currently names estradiol spray in its published formulary. We show the zero rather than infer an option from intake-only claims.

Estradiol cream

3 providers

Estradiol pill

3 providers

Estradiol vaginal

4 providers

Prices are each platform's own published figures for that form, read from our provider data and re-verified on the schedule shown on each review page. A vaginal cream appears under both Cream and Vaginal because it answers both questions. We earn a commission from some of these platforms, disclosed on every page, and it never affects the score or this order.

If you need a new prescriber who can write a patch or another form, Gala Health's flat plan advertises $69 a month with care, prescription and shipping, and names estradiol pills, patches and vaginal estradiol among the options. Its separate patch offer bills $297 every 12 weeks. We read both pages on September 24, 2026. A listed patch does not confirm pharmacy stock, so read the Gala Health review and confirm your exact prescription during the assessment.

These 5 featured menopause providers follow the same scoring methodology; commission does not determine their scores. For the same data pivoted provider first, with each platform's patch status alongside, use the Estradiol Patch Alternative Tracker. Compare everything on the full rankings or estimate cost with the HRT cost calculator.

What else should I ask before switching?

Is estradiol gel as good as the patch?

FDA-approved estradiol gels and patches can both treat menopausal hot flashes, but their doses and application instructions differ. A route label alone does not prove that two products are interchangeable. Ask your prescriber which product fits your history, and check its cost and availability with your pharmacy.

Where can I check the FDA's estradiol patch supply information?

Use the FDA supply statement and Drug Shortages page linked in this guide. The September 3, 2026 statement acknowledges access difficulties while noting that patches remain available. ASHP publishes a separate product-level bulletin. A national report does not confirm whether your pharmacy has your prescribed patch.

Is Dotti on back order in every strength?

Not in the ASHP bulletin dated August 12, 2026, checked October 12, 2026. Dotti: 0.025, 0.05 and 0.075 mg/day available; 0.0375 and 0.1 mg/day backordered without a release estimate. This is manufacturer supply reporting, not today's pharmacy inventory. Ask your pharmacist about the exact strength on your prescription.

What does the Sandoz estradiol patch shortage report say?

The ASHP bulletin dated August 12, 2026, checked October 12, 2026, reports Sandoz once-weekly patches as follows: 0.0375 and 0.1 mg/day backordered; remaining strengths allocated. Contact your pharmacy about your prescribed product; do not change strengths or schedules yourself.

Is anyone acting on the estrogen patch shortage?

Yes. The FDA published an update on September 3, 2026, describing work with all six manufacturers to increase supply. Its guidance is to contact your pharmacist and healthcare provider if your usual patch is unavailable.

Can I cut an estradiol patch to make the dose I need?

Do not cut a patch or combine strengths without specific instructions from your prescriber and pharmacist. ASHP warns that reservoir patches must never be cut and that cutting matrix patches can change dose release and stability. Ask about an appropriate alternative product or prescribed strength instead.

What can I take instead of the estradiol patch?

A clinician may consider another patch, an estradiol gel such as Divigel, a spray, an oral product or, when appropriate, a systemic vaginal ring such as Femring. Estring is a local vaginal treatment for vulvar and vaginal symptoms; it is not an interchangeable replacement for a patch used for hot flashes. Treatment choice and dose require a prescriber, and compounded products are not FDA-approved.

This is general information, not medical advice. HRT is a prescription medical treatment; whether and how to switch estrogen forms depends on your health history and must be decided with a licensed clinician. HRT Picks is not a medical provider and has no role in your care. National supply reports have their own publication dates; pharmacy inventory is unverified.

Get a monthly read on the HRT market.

Pricing changes, formulary updates, shortage status. One short email per month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.